Home
|
Contact
|
Pharmacovigilance
|
Medical Information
|
ITA
ENG
Welcome to
Chiesi group
Enter at least 3 characters
About us
History
Mission and Values
Governance
Benefit Corporation and B Corp
Annual and Sustainability Report
Chiesi in the world
Main areas
Research and Development
Pipeline
Clinical Trial Transparency and Data Sharing
Chiesi Clinical Studies
Manufacturing plants
Partnering
Why Chiesi as a partner
Therapeutic Focus
Who we are
Where we are
Events
Open Innovation - The Impulse
Digital Health
Working at Chiesi
Sustainability
Our approach
Ethics and Transparency
Patients at the Center
Environment
Global Value Chain
Chiesi people
Communities
Media area
News
Press Release
Contact
Home
>
Report EFPIA Countries
AUSTRIA
BELGIUM
BULGARIA
DENMARK
FINLAND
FRANCE
GERMANY
GREECE
ITALY
NORWAY
THE NETHERLANDS
POLAND
UK
CZECH REPUBLIC
SLOVAC REPUBLIC
ROMANIA
RUSSIA
SLOVENIA
SPAIN
SWEDEN
SWITZERLAND
HUNGARY
CHIESI ON THE WEB
Australia
Chiesi Australia
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi SA/NV
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria EOOD
Canada
Chiesi Canada Corp
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
Denmark
Chiesi Pharma AB
Finland
Chiesi Pharma AB
France
Chiesi SAS
Germany
Chiesi GmbH
Greece
Chiesi Hellas Α.Ε.Β.Ε.
Hungary
Chiesi Hungary Kft.
Italy
CHIESI Italia S.p.A.
Japan
Chiesi Pharma Japan Co.
Mexico
CHIESI MÉXICO
Norway
Chiesi Pharma AB
Pakistan
CHIESI PAKISTAN
Poland
Chiesi Poland
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
CHIESI ESPAÑA S.A.U
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaç Ticaret A.Ş
United Kingdom
Chiesi Limited
United States
Chiesi Usa, Inc.
